Skip to main content
Journal ArticleOPEN ACCESS

PCSK9 inhibition for primary prevention of ischaemic heart disease in heterozygous familial hypercholesterolaemia

Cochrane Database of Systematic Reviews (2018) 2018(1)
DOI: 10.1002/14651858.CD012917
1Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of PCSK9 inhibitors in the primary prevention of IHD in people with HeFH.

Cite

CITATION STYLE

APA

Ryan, A., Nevitt, S. J., Byrne, C. D., & Cook, P. (2018). PCSK9 inhibition for primary prevention of ischaemic heart disease in heterozygous familial hypercholesterolaemia. Cochrane Database of Systematic Reviews, 2018(1). https://doi.org/10.1002/14651858.CD012917

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free